BiotechTube

Donepezil Hydrochloride

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Dementia With Lewy Body Disease

Conditions

Dementia With Lewy Body Disease

Trial Timeline

Apr 20, 2015 → Mar 30, 2017

NCT ID
NCT02448784

About Donepezil Hydrochloride

Donepezil Hydrochloride is a pre-clinical stage product being developed by Eisai for Dementia With Lewy Body Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT02448784. Target conditions include Dementia With Lewy Body Disease.

What happened to similar drugs?

9 of 20 similar drugs in Dementia With Lewy Body Disease were approved

Approved (9) Terminated (1) Active (10)
✅E2020 + PlaceboEisaiApproved
✅donepezil hydrochloride (Aricept)EisaiApproved
✅MecobalaminEisaiApproved
✅Donepezil hydrochloride + Donepezil matching placebo + Donepezil hydrochlorideEisaiApproved
✅Risperdal,reminylJohnson & JohnsonApproved
✅ENA713NovartisApproved
✅Rivastigmine Patch 9.5 cm2NovartisApproved

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (11)

NCT IDPhaseStatus
NCT02448784Pre-clinicalCompleted
NCT02162264Pre-clinicalCompleted
NCT02162251Pre-clinicalCompleted
NCT01251718Pre-clinicalCompleted
NCT01129596Pre-clinicalCompleted
NCT00477659ApprovedCompleted
NCT00165750ApprovedTerminated
NCT00165724ApprovedCompleted
NCT00165737Phase 3Completed
NCT00165659Phase 2Completed
NCT00096473Phase 3Completed

Competing Products

20 competing products in Dementia With Lewy Body Disease

See all competitors
ProductCompanyStageHype Score
[18F]NAV4694Navidea BiopharmaceuticalsPhase 3
26
AL001 + Placebo + Open label - AL001AlectorPhase 3
22
AL001AlectorPhase 2
25
ATH-1017 + PlaceboLeonaBioPhase 2
17
IGC AD1 + PlaceboIGC PharmaPhase 1
19
E2020 + PlaceboEisaiApproved
43
ARICEPTEisaiPhase 3
40
RasagilineEisaiPhase 2
35
donepezil hclEisaiPhase 3
40
Donepezil 5 mg + Donepezil 10 mg + Donepezil matched placeboEisaiPhase 3
40
E2020 + E2020EisaiPhase 2
35
donepezil hydrochloride (Aricept)EisaiApproved
43
3 mg Donepezil hydrochloride + 5 mg Donepezil hydrochloride + 10 mg Donepezil hydrochloride + PlaceboEisaiPhase 2
35
E2020 + E2020EisaiPhase 3
40
Irsenontrine + PlaceboEisaiPhase 2
35
E2020EisaiPhase 2
35
MecobalaminEisaiApproved
43
E2020 + PlaceboEisaiPhase 3
40
Donepezil HydrochlorideEisaiPhase 3
40
Donepezil hydrochloride + Donepezil matching placebo + Donepezil hydrochlorideEisaiApproved
43